(CercleFinance.com) – LNA Santé manages to stay balanced in a clearly downward Parisian market, helped by comments from Oddo BHF, which raises its opinion on the stock from ‘neutral’ to ‘outperforming’ with a target price of 42 euros.
‘LNA Santé continues to appear as a virtuous player, although illiquid’, judges the analyst, who shows a preference for this title compared to its peers Korian and Orpéa in the current context of the healthcare sector. the addiction.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
